BHSTNGMConsumer Staples·Packaged Foods#40 in industry

BioHarvest Sciences Inc.

Reports in 17d· 2026-05-14

-12.8% · 90d

$4.38

-0.00 (-0.00%)

After-Hours $4.33(-0.05)

News

(1)

March 2026

Mar 31, 20263 weeks ago40-FConsumer Staples

BIOHARVEST SCIENCES INC. — 40-F Filing

BHSTBIOHARVEST SCIENCES INC.

# 🧾 What This Document Is This is BIOHARVEST SCIENCES INC.'s **Annual Information Form (AIF)**, filed as part of its 40-F annual report with the SEC. Think of it as a comprehensive "owner's manual" that publicly traded companies must update yearly. It details the company's business, risk factors, m

Read summaryView on SEC EDGAR

Key Data

Market Cap$99.3M

Open$4.38

Prev Close$4.38

Day Range$4.27 – $4.40

52W Range$4.10 – $12.80

Volume4,709

P/E (TTM)—

EPS$-0.60

Dividend Yield—

Beta1.40

Profit Margin-32.27%

Revenue Growth24.60%

Price Target$12.75(+191.1%)

Next Earnings2026-05-14(17d)

Analyst Ratings

Strong Buy4 analysts

Buy 4Hold 0Sell 0

About

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Consumer Staples · Packaged Foods

89 employees

www.bioharvest.com